The global Recurrent Atrial Fibrillation Market is expected to reach USD 25.93 Billion by 2027, according to a new report by Emergen Research. The report utilizes Porter’s Five Forces analysis to offer accurate predictions about the growth rate of the market. The study investigates and assesses the global Recurrent Atrial Fibrillation market in terms of market size, market share, and revenue generation. The report also assesses the growth of the segments of the Recurrent Atrial Fibrillation market over the forecast timeline.

Factors driving this market include augmenting incidence rate of recurrent atrial fibrillation, new product launches for effective treatment of recurrent events, and improved reimbursement scenarios for recurrent AFib treatment drugs along with technological advancements are expected to become the most common growth factors globally in the coming years. Moreover, healthcare experts from the University of Pennsylvania have estimated that patients admitted to intensive care units for COVID-19 treatment are more likely to suffer from arrhythmia and atrial fibrillation. This would be alarming for cardiac patients and would lead to increased sales of atrial fibrillation associated drugs.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/71

Key Highlights From The Report

• The prevalence of AFib ranges between 2.7 million and 6.1 million in the U.S. alone and is estimated to reach 12.1 million by the year 2030, according to the statistics of the Center for Disease Control. Similar incidence rates are observed in other regions as well, indicating potential growth in the target industry.
• Recently, in December 2019, the opening generic version of the blood thinner Eliquis received approval by the U.S. FDA. The drug is anticipated to provide quality treatment alternatives at affordable prices, especially for recurrent AFib patients, by reducing the risk of recurrence.
• The device type product segment is estimated to reach USD 5.88 billion by the year 2027 at a CAGR of 14.0% during the forecast period.
• Electrophysiology can estimate the electrical activity of the heart while the catheter ablation technique is used to treat arrhythmia of specific types. Electrophysiology is regarded as the most effective method for recurrent episodes of atrial fibrillation after drugs remain ineffective to the patient’s body.
• Key participants contributing significant market shares in the industry growth includes Johnson & Johnson, Medtronic Plc, Abbott Laboratories, Microport Scientific Corporation, Atricure Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Siemens AG, Koninklijke Philips N.V., AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, and GlaxoSmithKline.

Recurrent Atrial Fibrillation Market Segmentation:

Emergen Research have segmented the global Recurrent Atrial Fibrillation Market on the basis of product, application, end-uses, and region:

• Product Outlook (Revenue, USD Billion; 2017-2027)
  • Device
  • Surgical Devices
    1. Maze Surgery
    2. Catheter Ablation
    3. Radiofrequency Catheter Ablation
       1. Conventional RF Ablation Catheters
       2. Irrigated-tip RF Ablation Catheters
    4. Cryoablation
    5. Microwave Based Catheter Ablation
    6. Laser Based Catheter Ablation
    7. Navigational Advanced Mapping Accessories
  • Non-Surgical Devices
    1. Electric Cardioversion
    2. EP Ablation Catheters
    3. EP Diagnostic Catheter
    4. Conventional Diagnostic Catheters
       1. Fixed Diagnostic Catheters
       2. Steerable Diagnostic Catheters
    5. Advanced Diagnostic Catheters
    6. Mapping and Recording Systems
    7. Cardiac Monitors or Loop Recorders
    8. Access Devices
    9. Left Atrial Appendage and Closure Devices
    10. Intracardiac Echocardiography (ICE) Systems
  • Drugs
    1. Dabigatran (Pradaxa)
    2. Rivaroxaban (Xarelto)
    3. Apixaban (Eliquis)
    4. Edoxaban (Savaysa)
    5. Warfarin (Coumadin)
    6. Others
  • Application Outlook (Revenue, USD Billion; 2017-2027)
    • EP Ablation
    • Diagnostic
    • Surgical Cardiac
  • End Users Outlook (Revenue, USD Billion; 2017-2027)
    • Hospitals
    • Cardiac Centers
    • Ambulatory Care Centers

The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, AsiaPacific, and Middle East & Africa.In conclusion, the research report on the Recurrent Atrial Fibrillation market assesses growth prospects, opportunities, challenges, risks, threats, and trends to offer a comprehensive idea of the regional and global Recurrent Atrial Fibrillation market.

Request a customized copy of the Recurrent Atrial Fibrillation market report @ https://www.emergenresearch.com/request-for-customization/71

Key highlights of the report:

• The latest report performs an in-depth study of the potential opportunities and risks associated with the global Recurrent Atrial Fibrillation market, alongside studying the recent innovations and major events.
• The report underlines the niche segments/regions that exhibit potential growth over the forecast timeframe.
• The report analyzes numerous business expansion strategies adopted by the contending companies in this market.
• A detailed synopsis of the market includes the rapidly changing market dynamics and accurate prediction of the current, historical, and forecast market sizes in terms of volume and value.

Table Of Content:

Chapter 1. Methodology & Sources
    1.1. Market Definition
    1.2. Research Scope
    1.3. Methodology
    1.4. Research Sources
          1.4.1. Primary
          1.4.2. Secondary
          1.4.3. Paid Sources
    1.5. Market Estimation Technique
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Recurrent Atrial Fibrillation Market Segmentation & Impact Analysis
    4.1. Recurrent Atrial Fibrillation Market Material Segmentation Analysis
    4.2. Industrial Outlook
          4.2.1. Market indicators analysis
          4.2.2. Market drivers analysis
                    4.2.2.1. Rising incidence of heart diseases
                    4.2.2.2. Growing demand of the minimally invasive procedures
                    4.2.2.3. Technological advancement
    4.3. Market restraints analysis
                    4.3.1.1. High Cost of devices
    4.4. Technological Insights
    4.5. Regulatory Framework
    4.6. Porter’s Five Forces Analysis
    4.7. Competitive Metric Space Analysis
    4.8. Price trend Analysis
    4.9. Covid-19 Impact Analysis

READ MORE…!

Gain access to the full report by clicking here on the link @ https://www.emergenresearch.com/industry-report/recurrent-atrial-fibrillation-market

Thank you for reading our report. Customization of this report is available as per client requirements. Please connect with us to know more about the report, and our team will ensure you get the report tailored according to your needs.

Have a Look at Related Reports:

Autoinjectors Market@ https://www.emergenresearch.com/industry-report/autoinjectors-market

Blockchain Supply Chain Market@ https://www.emergenresearch.com/industry-report/blockchain-supply-c...

Non-Volatile Memory Express (NVMe) Market@ https://www.emergenresearch.com/industry-report/non-volatile-memory...

IoT in Education Market@ https://www.emergenresearch.com/industry-report/iot-in-education-ma...

Hemodynamic Monitoring Devices Market@ https://www.emergenresearch.com/industry-report/hemodynamic-monitor...

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkdIn | Twitter | Blogs